Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F20%3A73604618" target="_blank" >RIV/61989592:15310/20:73604618 - isvavai.cz</a>
Alternative codes found
RIV/61389030:_____/20:00523649 RIV/00216275:25310/20:39916447 RIV/00216208:11310/20:10414362
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S0223523420300039" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0223523420300039</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejmech.2020.112036" target="_blank" >10.1016/j.ejmech.2020.112036</a>

Result language
angličtina
Original language name
Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells
Original language description
Here, we describe the synthesis and biological characterization of 32 novel phenylalanine and leucine dipeptides modified on both the N and C termini by salicylic acid and aromatic or alicyclic amines, respectively. All compounds displayed anti proliferative activity in the tested cancer cell lines and eight of the compounds exhibited single digit micromolar GI(50) values. Treated cells rapidly detached from surface of tissue culture dishes and we found that focal adhesion kinase (FAK), p130CAS and paxillin, which are important regulators of cell adhesion, were dephosphorylated at Y397, Y410 and Y118, respectively. The most potent compound reduced proliferation in the HCT-116 cell line in a dose-dependent manner, as shown by a decrease in 5-bromo-2'-deoxyuridine incorporation into DNA. Furthermore, this compound increased the levels of several apoptotic markers, including activated caspases, and increased site-specific poly-(ADP-ribose)polymerase (PARP) cleavage.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry

Project
<a href="/en/project/GA18-03847S" target="_blank" >GA18-03847S: Pseudopeptide proteasome inhibitors</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)